NGF and GDNF in Behçet’s disease: linking neurotrophic factors to immune regulation
OBJECTIVE: Nerve growth factor (NGF) and glial cell line-derived neurotrophic factor (GDNF) are proteins that support the growth and survival […]
Rheumatology
Rheumatology
Impact of TNF-α inhibitor therapy on cardiovascular outcomes in ankylosing spondylitis: a nationwide population-based study
OBJECTIVE: This study aimed to evaluate the association between tumor necrosis factor-α inhibitor (TNFi) therapy and cardiovascular (CV) outcomes, as
Rheumatology
Efficacy of formic acid in combination with cDMARDs in rheumatoid arthritis
OBJECTIVE: The immune system of the body mistakenly targets its own joints in rheumatoid arthritis (RA), a chronic autoimmune disease
Rheumatology
Unraveling the joints: a narrative review of osteoarthritis
Osteoarthritis (OA) is a chronic and progressive degenerative disease that affects joint structures, such as the hips, knees, and hands,
Rheumatology
The retrospective evaluation of efficacy and safety data after switching from originator rituximab to biosimilar rituximab (CT-P10) in patients diagnosed with systemic lupus erythematosus: a single-center experience
OBJECTIVE: In our study, we analyzed the efficacy and safety data of patients with systemic lupus erythematosus (SLE) after switching
Rheumatology
Efficacy and safety of total glucosides of paeony in treating primary Sjögren’s syndrome: a propensity-matched study
OBJECTIVE: This study aimed to evaluate the efficacy and safety of total glucosides of paeony (TGP) in patients with primary
Rheumatology
Mortality associated with polymyalgia rheumatica in the United States in the 1999-2020 period: a multiple-cause-of-death study
OBJECTIVE: Multicause-of-death methods were used to analyze mortality and leading causes of death associated with polymyalgia rheumatica (PMR) in the
Rheumatology
Pan-immune-inflammation value could be a new marker to differentiate between vascular Behçet’s disease and non-vascular Behçet’s disease
OBJECTIVE: Behçet’s disease etiology is uncertain, and no specific diagnostic markers exist in the laboratory. This retrospective study aimed to
Rheumatology
Clinical and serological characteristics of anti-Ro/SS-A and anti-La/SS-B negative primary Sjögren’s syndrome: a comparative study
OBJECTIVE: This study aimed to describe the clinical spectrum of primary Sjögren’s syndrome (pSS) patients with anti-Ro/SS-A and anti-La/SS-B negativity.
Rheumatology
Nailfold capillaroscopy abnormalities and pulmonary hypertension in mixed connective tissue disease and systemic sclerosis patients
OBJECTIVE: Pulmonary arterial hypertension (PAH) represents an important vascular complication of mixed connective tissue disease (MCTD) and systemic sclerosis (SSc).
Rheumatology Network Articles
Early Rhythm Control Therapy for Atrial Fibrillation Unchanged by Diabetes, Obesity
Despite obesity’s well-known influence on AF recurrence, neither comorbidity has a significant influence on outcomes from early rhythm control therapy.
Rheumatology Network Articles
FDA Grants NRX-100 Fast Track Designation for Suicidal Ideation
FDA grants Fast Track to NRX-100, the first preservative-free IV ketamine, for treating suicidal ideation in depression.
Rheumatology Network Articles
FDA Approves PharmaTher’s Ketamine for Surgical Pain Management
After overcoming 2 FDA rejections, PharmaTher secures approval for ketamine (KETARX) in surgical pain.
The Rheumatologist
Advancing Equity and Access to Care with the Association of Women in Rheumatology
At the recent Association of Women in Rheumatology annual conference, AWIR and ACR leaders discussed advocacy’s important role in supporting
The Rheumatologist
Lowest Price, Highest Risk? New Drug Policy’s Potential Effect on Rheumatology
On July 31, President Trump sent formal letters to the CEOs of 17 major pharmaceutical companies, laying out several requirements
The Rheumatologist
Rheumatology Could Face New Challenges Under Drug Tariff Reforms
A 15% tariff on all European Union exports, including pharmaceuticals, went into effect on Aug. 7. The tariff could impact
Rheumatology Network Articles
HCPLive Five – Dermatology Updates at DERM 2025 NP/PA Conference
Counting down the most impactful news at major medical meetings, it’s the HCPLive Five! This episode focuses on 5 key
Rheumatology Network Articles
Improving Access and Addressing Gaps in Guidelines and Emerging Therapies
Panelists discuss how access challenges include insurance barriers and prior authorizations for medications, while identifying key gaps in eosinophilic esophagitis
Helio.com
Cell therapy represents ‘fascinating new chapter’ in rheumatology
The use of cell therapy in rheumatology is likely to expand considerably in the coming years, according to a presenter
The Rheumatologist
DOJ Tightens Oversight of DEI Programs: Implications for Rheumatology
A July 30 memo from Attorney General Pam Bondi clarifies how federal anti-discrimination laws apply to programs that might involve
The Rheumatologist
Countdown to ACR Convergence 2025: Early Registration Ends Aug. 21
Learn about the registration options and add-on opportunities associated with ACR Convergence 2025, to be held Oct. 24–29 in Chicago,
Nature Reviews Rheumatology
Parathyroid hormone receptor agonists in the management of osteoporosis
Nature Reviews Rheumatology, Published online: 11 August 2025; doi:10.1038/s41584-025-01287-w This Review summarizes clinical effectiveness, health economics and safety data on
Rheumatology Network Articles
HCPLive 5 Stories in Under 5: Week of 08/03
An audio recap of the top 5 stories in healthcare news from the week of 08/03-08/09.
Rheumatology Network Articles
High-Volume Intravitreal Injections Show No Increased Glaucoma Risk, with Deepak Sambhara, MD
Avacincaptad pegol, pegcetacoplan, and aflibercept 8mg do not increase risk of ocular hypertension and glaucoma, despite having higher volumes.
Rheumatology Network Articles
8 Dermatology Headlines You May Have Missed in July 2025
This summary of dermatology news coverage from the month of August 2025 highlights some of the most notable stories in
The Rheumatologist
The What, Why & How of MIPS Exception Applications
Practices that have experienced extreme circumstances—including wildfires or flooding—can apply for exceptions for Quality Payment Program reporting. Applications for 2025
The Rheumatologist
The ACR Advocates for Reinstatement of Members of CDC’s Advisory Committee on Immunization Practices
With 20 partner organizations, the ACR submitted a letter to HHS Secretary Robert F. Kennedy, Jr., urging the reinstatement of